NOS1 and muscular dystrophy: This may be particularly effective in conditions where nNOS expression is reduced, such as muscular dystrophy, heart failure, etc. (Thomas et al. 1998, 2003; Sander et al. 2000; Vongpatanasin et al. 2011; Notarius et al. 2014).